Literature DB >> 22266885

Epigenetics in nucleotide repeat expansion disorders.

Fang He1, Peter K Todd.   

Abstract

Over the past 20 years, nucleotide repeat expansion disorders have informed our broader understanding of neurodevelopmental and neurodegenerative disease. This is especially true with regard to the contributions of epigenetic mechanisms to neurologic disease pathogenesis. In this review, the authors describe a few of the myriad ways in which epigenetic processes underlie aspects of repeat expansion disorder pathophysiology and discuss how therapies targeted at epigenetic modulation hold promise for many of these disorders. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266885      PMCID: PMC3655547          DOI: 10.1055/s-0031-1299786

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  156 in total

1.  New polymorphism and a new chromosome breakpoint establish the physical and genetic mapping of DXS369 in the DXS98-FRAXA interval.

Authors:  I Oberlé; A Vincent; N Abbadi; F Rousseau; P E Hupkes; M C Hors-Cayla; S Gilgenkrantz; B A Oostra; J L Mandel
Journal:  Am J Med Genet       Date:  1991 Feb-Mar

2.  Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.

Authors:  Faraz Farzin; Hazel Perry; David Hessl; Danuta Loesch; Jonathan Cohen; Susan Bacalman; Louise Gane; Flora Tassone; Paul Hagerman; Randi Hagerman
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

3.  Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts.

Authors:  P S Sarkar; B Appukuttan; J Han; Y Ito; C Ai; W Tsai; Y Chai; J T Stout; S Reddy
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

4.  Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells.

Authors:  A Kazantsev; E Preisinger; A Dranovsky; D Goldgaber; D Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Tip60 is a nuclear hormone receptor coactivator.

Authors:  M E Brady; D M Ozanne; L Gaughan; I Waite; S Cook; D E Neal; C N Robson
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

6.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

7.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.

Authors:  J S Steffan; L Bodai; J Pallos; M Poelman; A McCampbell; B L Apostol; A Kazantsev; E Schmidt; Y Z Zhu; M Greenwald; R Kurokawa; D E Housman; G R Jackson; J L Marsh; L M Thompson
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

8.  Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease.

Authors:  Judit Pallos; Laszlo Bodai; Tamas Lukacsovich; Judith M Purcell; Joan S Steffan; Leslie Michels Thompson; J Lawrence Marsh
Journal:  Hum Mol Genet       Date:  2008-09-01       Impact factor: 6.150

9.  Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome.

Authors:  Peter K Todd; Seok Yoon Oh; Amy Krans; Udai B Pandey; Nicholas A Di Prospero; Kyung-Tai Min; J Paul Taylor; Henry L Paulson
Journal:  PLoS Genet       Date:  2010-12-09       Impact factor: 5.917

10.  Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.

Authors:  K L Taneja; M McCurrach; M Schalling; D Housman; R H Singer
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  18 in total

Review 1.  Mechanisms of toxicity in C9FTLD/ALS.

Authors:  Tania F Gendron; Veronique V Belzil; Yong-Jie Zhang; Leonard Petrucelli
Journal:  Acta Neuropathol       Date:  2014-01-07       Impact factor: 17.088

Review 2.  Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease.

Authors:  Charis L Himeda; Takako I Jones; Peter L Jones
Journal:  Antioxid Redox Signal       Date:  2014-12-04       Impact factor: 8.401

Review 3.  There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.

Authors:  Aaron D Gitler; Hitomi Tsuiji
Journal:  Brain Res       Date:  2016-04-06       Impact factor: 3.252

4.  Bromodomain inhibitors regulate the C9ORF72 locus in ALS.

Authors:  Zane Zeier; Rustam Esanov; Kinsley C Belle; Claude-Henry Volmar; Andrea L Johnstone; Paul Halley; Brooke A DeRosa; Nathalie Khoury; Marka van Blitterswijk; Rosa Rademakers; Jeffrey Albert; Shaun P Brothers; Joanne Wuu; Derek M Dykxhoorn; Michael Benatar; Claes Wahlestedt
Journal:  Exp Neurol       Date:  2015-06-20       Impact factor: 5.330

Review 5.  RAN translation-What makes it run?

Authors:  Katelyn M Green; Alexander E Linsalata; Peter K Todd
Journal:  Brain Res       Date:  2016-04-06       Impact factor: 3.252

Review 6.  Update on the Treatment of Ataxia: Medication and Emerging Therapies.

Authors:  Susan L Perlman
Journal:  Neurotherapeutics       Date:  2020-10-06       Impact factor: 7.620

7.  A Drosophila model of Huntington disease-like 2 exhibits nuclear toxicity and distinct pathogenic mechanisms from Huntington disease.

Authors:  Megan Krench; Richard W Cho; J Troy Littleton
Journal:  Hum Mol Genet       Date:  2016-06-10       Impact factor: 6.150

Review 8.  An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics.

Authors:  Sanjog R Chintalaphani; Sandy S Pineda; Ira W Deveson; Kishore R Kumar
Journal:  Acta Neuropathol Commun       Date:  2021-05-25       Impact factor: 7.801

Review 9.  Histone Methylation Regulation in Neurodegenerative Disorders.

Authors:  Balapal S Basavarajappa; Shivakumar Subbanna
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 10.  Epigenetic findings in autism: new perspectives for therapy.

Authors:  Dario Siniscalco; Alessandra Cirillo; James Jeffrey Bradstreet; Nicola Antonucci
Journal:  Int J Environ Res Public Health       Date:  2013-09-11       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.